Bharat Biotech invests Rs 600 cr to expand into cell, gene therapies

As per Bharat Biotech, the facility will tackle scientific challenges such as targeted gene expression, immune system modulation, and long-term cell survival. Work will span from boosting immune responses against cancer to ensuring that therapeutic proteins are safely accepted in patients with genetic diseases like haemophilia.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3kEcSD0
via IFTTT